Praetorian Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing March 16, 2026

Miami, FL, March 13, 2026 -- Praetorian Acquisition Corp. (Nasdaq: PTORU) (the “Company”) announced today that, commencing March 16, 2026, the holders of the units issued in the Company’s initial public offering (the “Units”), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-third of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants will trade on the Nasdaq Global Market under the symbols “PTOR” and “PTORW,” respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol “PTORU.”
 
Clear Street LLC acted as sole book-running manager for the offering.
 

 
 
The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with an attractive target business in a traditional sector that can be transformed through the application of automation and artificial intelligence.
 
The Company’s management team is led by Justin Di Rezze M.D., its Chief Executive Officer, and Peter Ondishin, its Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Nicole Seligman, Alex Elias and Erica Dorfman.
 
 
 

 
 
Praetorian Acquisition Corp.
Justin Di Rezze M.D., Chief Executive Officer